ad
This Article
Right arrow Full Version
Right arrow PDF Español
Right arrowAn erratum has been published
Services
Right arrow E-mail this link to a friend
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices
Right arrow Earn CME - What's This?
Related Collections
Right arrowRelated Articles

The following text is from an archived Red Book® edition and may not reflect current recommendations or information. To view the current edition, click here.

Section 1. Active and Passive Immunization

PASSIVE IMMUNIZATION

Treatment of Anaphylactic Reactions

Personnel administering biologic products or serum should be prepared to recognize and treat systemic anaphylaxis. The medications, equipment, and competent staff necessary to maintain the patency of the airway and to manage cardiovascular collapse must be available immediately. Appropriate and timely transfer of a patient with anaphylaxis to a pediatric intensive care unit or a hospital emergency department may be necessary.

The emergency treatment of systemic anaphylactic reactions is based on the type of reaction. In all instances, epinephrine is the primary drug. Mild symptoms of pruritus, erythema, urticaria, and angioedema should be treated with epinephrine injected intramuscularly, followed by diphenhydramine, hydroxyzine, or other antihistamine given orally or parenterally (see Tables 1.11. . . [Go to Full Text]


Related Articles

Vaccine Safety and Contraindications
Red Book 2003 2003: 37-49. [Extract] [Full Text]

Antibodies of Animal Origin (Animal Antisera)
Red Book 2003 2003: 60-63. [Extract] [Full Text]